IO Biotech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-86.08	-71.46	-74.99	-14.59	-12.52
Depreciation & Amortization	0.76	0.54	0	0	0
Share-Based Compensation	8.06	7.04	1.79	0.06	0.13
Other Operating Activities	5.53	4.15	25.44	2.02	1.72
Operating Cash Flow	-71.74	-59.73	-40.65	-9.96	-8.89
Capital Expenditures	-0.32	-0.69	-0.15	0	0
Investing Cash Flow	-0.32	-0.69	-0.15	0	0
Share Issuance / Repurchase	71.86	0	103.35	0	0
Debt Issued / Paid	0	0	0	0	9.01
Other Financing Activities	-	-	149.6	5.1	-
Financing Cash Flow	71.86	0	252.95	5.1	9.01
Exchange Rate Effect	0.8	-8.52	-3.76	0.41	-0.25
Net Cash Flow	-0.2	-60.42	212.15	-4.85	0.12
Free Cash Flow	-72.06	-60.42	-40.8	-9.96	-8.89
Free Cash Flow Per Share	-1.66	-2.10	-9.41	-56.19	-50.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).